Sector Chart Avalo Therapeutics, Inc.

Equities

AVTX

US05338F3064

Market Closed - Nasdaq 16:00:00 2024-05-24 EDT 5-day change 1st Jan Change
13.1 USD +17.49% Intraday chart for Avalo Therapeutics, Inc. +36.60% +43.96%
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Other Biotechnology & Medical Research

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
13.55M - - - - -
63.85B -
41.83B
40.65B
27.12B
26.52B